rhodioloside has been researched along with 1-(2,4-dichlorobenzyl)indazole-3-carbohydrazide in 1 studies
| Studies (rhodioloside) | Trials (rhodioloside) | Recent Studies (post-2010) (rhodioloside) | Studies (1-(2,4-dichlorobenzyl)indazole-3-carbohydrazide) | Trials (1-(2,4-dichlorobenzyl)indazole-3-carbohydrazide) | Recent Studies (post-2010) (1-(2,4-dichlorobenzyl)indazole-3-carbohydrazide) |
|---|---|---|---|---|---|
| 621 | 2 | 519 | 74 | 0 | 44 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buabeid, M; Dhanasekaran, M; Dwyer, D; Fabbrini, M; Fujihashi, A; Govindarajulu, M; Lynd, T; Mohanakumar, KP; Moore, T; Neel, L; Ramesh, S; Shah, K; Smith, F | 1 |
1 review(s) available for rhodioloside and 1-(2,4-dichlorobenzyl)indazole-3-carbohydrazide
| Article | Year |
|---|---|
Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Animals; Biphenyl Compounds; Dietary Supplements; Drug Delivery Systems; Enzyme Inhibitors; Glucosides; Humans; Hydrazines; Indazoles; Lignans; Neuroprotection; Phenols; Sirtuin 3 | 2021 |